Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F93W3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,954
Award facts
- Contract value 100% obligated
- $31,953.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,953.74 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen auto-injectors on November 24, 2025, with completion targeted for November 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical vendor within the DLA's Medical Supply Chain through its comprehensive portfolio of pharmaceutical products and medical supplies serving military and veteran healthcare systems. The parent IDC vehicle enables the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support global military healthcare programs. This delivery order for Dupixent—a biologic immunosuppressant commonly used to treat moderate-to-severe atopic dermatitis and other allergic conditions—reflects the contractor's ongoing role in fulfilling federal pharmaceutical procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F93W3?
SPE2DR26F93W3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F93W3 worth?
The government has obligated $31,954 on SPE2DR26F93W3.
Is contract SPE2DR26F93W3 an order under another contract?
Yes. SPE2DR26F93W3 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F93W3 competed?
The extent of competition for SPE2DR26F93W3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award